Senti Biosciences Ownership 2024 | Who Owns Senti Biosciences Now?
Institutional Ownership
22.70%
Insider Ownership
21.02%
Retail Ownership
56.28%
Institutional Holders
19.00
Senti Biosciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
NEA MANAGEMENT COMPANY, LLC | 9.68% | 0.09% | 4,426,151 | - | - | 1,221,618 | Jun 30, 2024 |
8VC GP I, LLC | 5.55% | 8.67% | 2,537,558 | - | - | 7,003,660 | Jun 30, 2024 |
ARK INVESTMENT MANAGEMENT LLC | 3.47% | 0.00% | 1,585,772 | -45,150 | -2.77% | 437,673 | Jun 30, 2024 |
VANGUARD GROUP INC | 1.55% | - | 707,052 | - | - | 195,146 | Jun 30, 2024 |
INTEL CORP | 1.30% | 0.03% | 595,665 | - | - | 164,404 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.54% | - | 245,590 | - | - | 67,798 | Jun 30, 2024 |
TWO SIGMA INVESTMENTS, LP | 0.15% | - | 69,751 | -23,870 | -25.50% | 19,251 | Jun 30, 2024 |
BLACKROCK INC. | 0.09% | - | 40,052 | - | - | 11,054 | Jun 30, 2024 |
STATE STREET CORP | 0.09% | - | 39,100 | - | - | 10,792,000 | Jun 30, 2024 |
NORTHERN TRUST CORP | 0.08% | - | 36,848 | - | - | 10,170,000 | Jun 30, 2024 |
ALLEN OPERATIONS LLC | 0.05% | 0.00% | 21,443 | - | - | 5,918 | Jun 30, 2024 |
TRIATOMIC MANAGEMENT LP | 0.03% | 0.13% | 15,493 | -295,040 | -95.01% | 4,276 | Jun 30, 2024 |
HRT FINANCIAL LP | 0.03% | - | 12,513 | 12,513 | 100.00% | 3,000 | Jun 30, 2024 |
MORGAN STANLEY | 0.01% | - | 5,396 | 3,796 | 237.25% | 1,490 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.01% | - | 3,823 | -4,691 | -55.10% | 1,055 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 820 | 579 | 240.25% | 227 | Jun 30, 2024 |
WOLVERINE ASSET MANAGEMENT LLC | 0.00% | - | 800 | - | - | 220 | Jun 30, 2024 |
TORONTO DOMINION BANK | 0.00% | - | 37 | - | - | 102 | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -202 | -100.00% | - | Jun 30, 2024 |
HARBOUR INVESTMENTS, INC. | - | - | - | -15,000 | -100.00% | - | Jun 30, 2024 |
Senti Biosciences's largest institutional shareholder is NEA MANAGEMENT COMPANY, LLC, holding 9.68% of the company's total share outstanding, currently valued at $1.22M. The top 10 institutional shareholders own together 22.50% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
8VC GP I, LLC | 5.55% | 8.67% | 2,537,558 | - | - | 7,003,660 | Jun 30, 2024 |
TRIATOMIC MANAGEMENT LP | 0.03% | 0.13% | 15,493 | -295,040 | -95.01% | 4,276 | Jun 30, 2024 |
NEA MANAGEMENT COMPANY, LLC | 9.68% | 0.09% | 4,426,151 | - | - | 1,221,618 | Jun 30, 2024 |
INTEL CORP | 1.30% | 0.03% | 595,665 | - | - | 164,404 | Jun 30, 2024 |
ARK INVESTMENT MANAGEMENT LLC | 3.47% | 0.00% | 1,585,772 | -45,150 | -2.77% | 437,673 | Jun 30, 2024 |
ALLEN OPERATIONS LLC | 0.05% | 0.00% | 21,443 | - | - | 5,918 | Jun 30, 2024 |
TWO SIGMA INVESTMENTS, LP | 0.15% | - | 69,751 | -23,870 | -25.50% | 19,251 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.01% | - | 3,823 | -4,691 | -55.10% | 1,055 | Jun 30, 2024 |
HRT FINANCIAL LP | 0.03% | - | 12,513 | 12,513 | 100.00% | 3,000 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.54% | - | 245,590 | - | - | 67,798 | Jun 30, 2024 |
VANGUARD GROUP INC | 1.55% | - | 707,052 | - | - | 195,146 | Jun 30, 2024 |
WOLVERINE ASSET MANAGEMENT LLC | 0.00% | - | 800 | - | - | 220 | Jun 30, 2024 |
NORTHERN TRUST CORP | 0.08% | - | 36,848 | - | - | 10,170,000 | Jun 30, 2024 |
STATE STREET CORP | 0.09% | - | 39,100 | - | - | 10,792,000 | Jun 30, 2024 |
BLACKROCK INC. | 0.09% | - | 40,052 | - | - | 11,054 | Jun 30, 2024 |
TORONTO DOMINION BANK | 0.00% | - | 37 | - | - | 102 | Jun 30, 2024 |
MORGAN STANLEY | 0.01% | - | 5,396 | 3,796 | 237.25% | 1,490 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 820 | 579 | 240.25% | 227 | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -202 | -100.00% | - | Jun 30, 2024 |
HARBOUR INVESTMENTS, INC. | - | - | - | -15,000 | -100.00% | - | Jun 30, 2024 |
The largest Senti Biosciences shareholder by % of total assets is 8VC GP I, LLC. The company owns 2.54M shares of Senti Biosciences (SNTI), representing 8.67% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
HRT FINANCIAL LP | 0.03% | - | 12,513 | 12,513 | 100.00% | 3,000 | Jun 30, 2024 |
MORGAN STANLEY | 0.01% | - | 5,396 | 3,796 | 237.25% | 1,490 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 820 | 579 | 240.25% | 227 | Jun 30, 2024 |
TORONTO DOMINION BANK | 0.00% | - | 37 | - | - | 102 | Jun 30, 2024 |
BLACKROCK INC. | 0.09% | - | 40,052 | - | - | 11,054 | Jun 30, 2024 |
STATE STREET CORP | 0.09% | - | 39,100 | - | - | 10,792,000 | Jun 30, 2024 |
NORTHERN TRUST CORP | 0.08% | - | 36,848 | - | - | 10,170,000 | Jun 30, 2024 |
WOLVERINE ASSET MANAGEMENT LLC | 0.00% | - | 800 | - | - | 220 | Jun 30, 2024 |
VANGUARD GROUP INC | 1.55% | - | 707,052 | - | - | 195,146 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.54% | - | 245,590 | - | - | 67,798 | Jun 30, 2024 |
ALLEN OPERATIONS LLC | 0.05% | 0.00% | 21,443 | - | - | 5,918 | Jun 30, 2024 |
INTEL CORP | 1.30% | 0.03% | 595,665 | - | - | 164,404 | Jun 30, 2024 |
NEA MANAGEMENT COMPANY, LLC | 9.68% | 0.09% | 4,426,151 | - | - | 1,221,618 | Jun 30, 2024 |
8VC GP I, LLC | 5.55% | 8.67% | 2,537,558 | - | - | 7,003,660 | Jun 30, 2024 |
COMERICA BANK | - | - | - | -48 | -100.00% | - | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -202 | -100.00% | - | Jun 30, 2024 |
UBS GROUP AG | - | - | - | -732 | -100.00% | - | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.01% | - | 3,823 | -4,691 | -55.10% | 1,055 | Jun 30, 2024 |
MILLENNIUM MANAGEMENT LLC | - | - | - | -13,337 | -100.00% | - | Jun 30, 2024 |
HARBOUR INVESTMENTS, INC. | - | - | - | -15,000 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Senti Biosciences's largest institutional buyer is HRT FINANCIAL LP. The company purchased 12.51K stocks of SNTI, valued at $3.00K.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
TRIATOMIC MANAGEMENT LP | 0.03% | 0.13% | 15,493 | -295,040 | -95.01% | 4,276 | Jun 30, 2024 |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -145,000 | -100.00% | - | Jun 30, 2024 |
ARK INVESTMENT MANAGEMENT LLC | 3.47% | 0.00% | 1,585,772 | -45,150 | -2.77% | 437,673 | Jun 30, 2024 |
RENAISSANCE TECHNOLOGIES LLC | - | - | - | -24,102 | -100.00% | - | Jun 30, 2024 |
TWO SIGMA INVESTMENTS, LP | 0.15% | - | 69,751 | -23,870 | -25.50% | 19,251 | Jun 30, 2024 |
VIRTU FINANCIAL LLC | - | - | - | -19,678 | -100.00% | - | Jun 30, 2024 |
HARBOUR INVESTMENTS, INC. | - | - | - | -15,000 | -100.00% | - | Jun 30, 2024 |
MILLENNIUM MANAGEMENT LLC | - | - | - | -13,337 | -100.00% | - | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.01% | - | 3,823 | -4,691 | -55.10% | 1,055 | Jun 30, 2024 |
UBS GROUP AG | - | - | - | -732 | -100.00% | - | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -202 | -100.00% | - | Jun 30, 2024 |
COMERICA BANK | - | - | - | -48 | -100.00% | - | Jun 30, 2024 |
8VC GP I, LLC | 5.55% | 8.67% | 2,537,558 | - | - | 7,003,660 | Jun 30, 2024 |
NEA MANAGEMENT COMPANY, LLC | 9.68% | 0.09% | 4,426,151 | - | - | 1,221,618 | Jun 30, 2024 |
INTEL CORP | 1.30% | 0.03% | 595,665 | - | - | 164,404 | Jun 30, 2024 |
ALLEN OPERATIONS LLC | 0.05% | 0.00% | 21,443 | - | - | 5,918 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.54% | - | 245,590 | - | - | 67,798 | Jun 30, 2024 |
VANGUARD GROUP INC | 1.55% | - | 707,052 | - | - | 195,146 | Jun 30, 2024 |
WOLVERINE ASSET MANAGEMENT LLC | 0.00% | - | 800 | - | - | 220 | Jun 30, 2024 |
NORTHERN TRUST CORP | 0.08% | - | 36,848 | - | - | 10,170,000 | Jun 30, 2024 |
As of Jun 30 2024, Senti Biosciences's biggest institutional seller is TRIATOMIC MANAGEMENT LP. The company sold -0.30M shares of SNTI, valued at $4.28K.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
HRT FINANCIAL LP | 0.03% | - | 12,513 | 12,513 | 100.00% | 3,000 | Jun 30, 2024 |
Senti Biosciences's largest new institutional shareholder by number of shares is HRT FINANCIAL LP, purchased 12.51K shares, valued at $3.00K, as of undefined.
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -145,000 | -100.00% | - | Jun 30, 2024 |
RENAISSANCE TECHNOLOGIES LLC | - | - | - | -24,102 | -100.00% | - | Jun 30, 2024 |
VIRTU FINANCIAL LLC | - | - | - | -19,678 | -100.00% | - | Jun 30, 2024 |
HARBOUR INVESTMENTS, INC. | - | - | - | -15,000 | -100.00% | - | Jun 30, 2024 |
MILLENNIUM MANAGEMENT LLC | - | - | - | -13,337 | -100.00% | - | Jun 30, 2024 |
UBS GROUP AG | - | - | - | -732 | -100.00% | - | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | - | - | - | -202 | -100.00% | - | Jun 30, 2024 |
COMERICA BANK | - | - | - | -48 | -100.00% | - | Jun 30, 2024 |
Senti Biosciences's largest sold out institutional shareholder by shares sold is BRIDGEWAY CAPITAL MANAGEMENT, LLC, sold -0.14M shares, valued at -, as of undefined.
Senti Biosciences Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
T. Rowe Price Health Sciences Fund, Inc. | 0.34% | 1,121,315 | - | - | Mar 31, 2024 |
T. Rowe Price New Horizons Fund, Inc. | 0.28% | 1,389,887 | - | - | Mar 31, 2024 |
Ark ETF Trust | 0.21% | 1,661,853 | -120,161 | -6.74% | Jan 31, 2024 |
BRIDGEWAY FUNDS INC | 0.06% | 145,000 | - | - | Mar 28, 2024 |
T. Rowe Price Equity Series, Inc. | 0.04% | 63,936 | - | - | Mar 31, 2024 |
MORGAN STANLEY INSTITUTIONAL FUND INC | 0.01% | 376,858 | - | - | Mar 31, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 707,052 | -386,899 | -35.37% | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 229,867 | 6,211 | 2.78% | Feb 29, 2024 |
ETF Series Solutions | 0.00% | 2,275 | - | - | Jan 31, 2024 |
EQ ADVISORS TRUST | 0.00% | 29,595 | - | - | Mar 31, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 2,834 | - | - | Jan 31, 2024 |
JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 18,231 | - | - | Mar 31, 2024 |
MASSMUTUAL SELECT FUNDS | 0.00% | 5,711 | - | - | Dec 31, 2023 |
John Hancock Funds II | 0.00% | 26,772 | - | - | Feb 29, 2024 |
Senti Biosciences's largest mutual fund holder by % of total assets is "T. Rowe Price Health Sciences Fund, Inc.", owning 1.12M shares, compromising 0.34% of its total assets.
Senti Biosciences Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
30 Jun, 24 | 19 | -29.63% |
31 Mar, 24 | 27 | 8.00% |
31 Dec, 23 | 25 | 4.17% |
30 Sep, 23 | 24 | -14.29% |
30 Jun, 23 | 28 | 16.67% |
31 Mar, 23 | 24 | -7.69% |
31 Dec, 22 | 26 | 13.04% |
30 Sep, 22 | 23 | 27.78% |
30 Jun, 22 | 18 | - |
As of 30 Jun 24, 19 institutions are holding Senti Biosciences's shares, representing a decrease of -29.63% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
30 Jun, 24 | 10,375,264 | -5.63% |
31 Mar, 24 | 10,994,171 | -4.07% |
31 Dec, 23 | 11,461,121 | -4.80% |
30 Sep, 23 | 12,038,399 | -1.33% |
30 Jun, 23 | 12,201,253 | -3.24% |
31 Mar, 23 | 12,610,070 | 1.67% |
31 Dec, 22 | 12,403,151 | -7.91% |
30 Sep, 22 | 13,468,041 | 13.14% |
30 Jun, 22 | 11,903,638 | - |
Senti Biosciences (SNTI) has 10.38M shares outstanding as of 30 Jun 24, down -5.63% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
30 Jun, 24 | 22.70% | 3.75% |
31 Mar, 24 | 24.62% | 3.71% |
31 Dec, 23 | 25.77% | 3.49% |
30 Sep, 23 | 27.19% | 3.55% |
30 Jun, 23 | 27.69% | 3.38% |
31 Mar, 23 | 28.61% | 3.57% |
31 Dec, 22 | 28.30% | 3.00% |
30 Sep, 22 | 30.73% | 0.39% |
30 Jun, 22 | 88.53% | - |
As of 30 Jun 24, Senti Biosciences is held by 22.70% institutional shareholders, representing a 3.75% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
30 Jun, 24 | 4 | -63.64% |
31 Mar, 24 | 11 | 10.00% |
31 Dec, 23 | 10 | 25.00% |
30 Sep, 23 | 8 | -33.33% |
30 Jun, 23 | 12 | 100.00% |
31 Mar, 23 | 6 | -45.45% |
31 Dec, 22 | 11 | -26.67% |
30 Sep, 22 | 15 | -16.67% |
30 Jun, 22 | 18 | - |
4 institutional shareholders have increased their position in SNTI stock as of 30 Jun 24 compared to 11 in the previous quarter (a -63.64% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
30 Jun, 24 | 4 | 33.33% |
31 Mar, 24 | 3 | 200.00% |
31 Dec, 23 | 1 | -66.67% |
30 Sep, 23 | 3 | -25.00% |
30 Jun, 23 | 4 | - |
31 Mar, 23 | 4 | -60.00% |
31 Dec, 22 | 10 | 900.00% |
30 Sep, 22 | 1 | - |
30 Jun, 22 | - | - |
4 institutional shareholders have reduced their position in SNTI stock as of 30 Jun 24 compared to 3 in the previous quarter (a 33.33% increase).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
30 Jun, 24 | 19 | -29.63% | 10,375,264 | -5.63% | 22.70% | 3.75% | 4 | -63.64% | 4 | 33.33% |
31 Mar, 24 | 27 | 8.00% | 10,994,171 | -4.07% | 24.62% | 3.71% | 11 | 10.00% | 3 | 200.00% |
31 Dec, 23 | 25 | 4.17% | 11,461,121 | -4.80% | 25.77% | 3.49% | 10 | 25.00% | 1 | -66.67% |
30 Sep, 23 | 24 | -14.29% | 12,038,399 | -1.33% | 27.19% | 3.55% | 8 | -33.33% | 3 | -25.00% |
30 Jun, 23 | 28 | 16.67% | 12,201,253 | -3.24% | 27.69% | 3.38% | 12 | 100.00% | 4 | - |
31 Mar, 23 | 24 | -7.69% | 12,610,070 | 1.67% | 28.61% | 3.57% | 6 | -45.45% | 4 | -60.00% |
31 Dec, 22 | 26 | 13.04% | 12,403,151 | -7.91% | 28.30% | 3.00% | 11 | -26.67% | 10 | 900.00% |
30 Sep, 22 | 23 | 27.78% | 13,468,041 | 13.14% | 30.73% | 0.39% | 15 | -16.67% | 1 | - |
30 Jun, 22 | 18 | - | 11,903,638 | - | 88.53% | - | 18 | - | - | - |
Senti Biosciences Insider Shareholders Trades
Open Market Insider Trades
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Open Market Insider Buys
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Insider Sells
All Insider Owners Trades
The last insider sell of Senti Biosciences's stock was made by BAYER HEALTHCARE LLC on Feb 13 2023, selling - shares at - per share (valued at -).
Senti Biosciences Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2024 | 4 | - | - |
Q2 2024 | - | - | - |
Q1 2024 | 6 | - | - |
Q2 2023 | 5 | - | - |
Q1 2023 | 4 | - | - |
Q4 2022 | 2 | - | - |
Q3 2022 | 10 | - | - |
Q2 2022 | 2 | 23 | 8.70% |
Q2 2021 | - | 2 | - |
Q2 2014 | 14 | 2 | 700.00% |
Q4 2013 | 1 | - | - |
Q3 2013 | 7 | - | - |
Q2 2013 | 5 | - | - |
Q1 2013 | 4 | - | - |
4 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Senti Biosciences's insiders, as of Q3 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2024 | - | - | - |
Q2 2024 | - | - | - |
Q1 2024 | - | - | - |
Q2 2023 | - | - | - |
Q1 2023 | - | - | - |
Q4 2022 | - | - | - |
Q3 2022 | - | - | - |
Q2 2022 | - | - | - |
Q2 2021 | - | - | - |
Q2 2014 | - | - | - |
Q4 2013 | 1 | - | - |
Q3 2013 | - | - | - |
Q2 2013 | 1 | - | - |
Q1 2013 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Senti Biosciences's stocks.
Senti Biosciences Peer Ownership
Ticker | Company |
---|---|
BLCM | Bellicum Pharmaceuticals, Inc. |
MNPR | Monopar Therapeutics Inc. |
FHTX | Foghorn Therapeutics Inc. |
MLYS | Mineralys Therapeutics, Inc. |
SABS | SAB Biotherapeutics, Inc. |
CVKD | Cadrenal Therapeutics, Inc. Common Stock |
QNRX | Quoin Pharmaceuticals, Ltd. |
FENC | Fennec Pharmaceuticals Inc. |
HILS | Tharimmune, Inc. |
TYRA | Tyra Biosciences, Inc. |
CING | Cingulate Inc. |
CNTB | Connect Biopharma Holdings Limited |
LIPO | Lipella Pharmaceuticals Inc. |
XLO | Xilio Therapeutics, Inc. |
NLTX | Neurogene Inc. |
RAPT | RAPT Therapeutics, Inc. |
SNTI Ownership FAQ
Who Owns Senti Biosciences?
Senti Biosciences is owned by institutional shareholders (22.70%), insiders (21.02%), and public (56.28%). The largest institutional shareholder of Senti Biosciences is NEA MANAGEMENT COMPANY, LLC (9.68% of total shares) and the top mutual fund owner is T. Rowe Price Health Sciences Fund, Inc. (0.34% of total shares).
Who are the major institutional shareholders of Senti Biosciences?
Senti Biosciences's major institutional shareholders are NEA MANAGEMENT COMPANY, LLC, 8VC GP I, LLC, ARK INVESTMENT MANAGEMENT LLC, VANGUARD GROUP INC, and INTEL CORP. The top five shareholders own together 21.55% of the company's share outstanding.
How many Senti Biosciences shareholders are there?
As of Jun 2024, there are 19 institutional shareholders of Senti Biosciences.
What percentage of Senti Biosciences is owned by NEA MANAGEMENT COMPANY, LLC?
NEA MANAGEMENT COMPANY, LLC owns 4.43M shares of Senti Biosciences, representing 9.68% of the company's total shares outstanding, valued at $1.22M (as of Jun 2024).
What percentage of Senti Biosciences is owned by 8VC GP I, LLC?
As of Jun 2024, 8VC GP I, LLC holds 2.54M shares of Senti Biosciences (SNTI), compromising 5.55% of the company, valued at $7M.
What percentage of Senti Biosciences is owned by ARK INVESTMENT MANAGEMENT LLC?
ARK INVESTMENT MANAGEMENT LLC is the third largest holder of Senti Biosciences. The company owns 1.59M of the company's shares outstanding (worth $437.67K).